Abstract
Introduction

Thrombotic thrombocytopenic purpura (TTP) is a rare but life-threatening disease, characterized by generalized microvascular occlusion by platelet thrombi (1, 2). TTP was classically identified by a clinical 'pentad' consisting of thrombocytopenia, microangiopathic hemolytic anemia, renal failure, fever, and fluctuating neurological signs (3). More recently, however, TTP, has been associated with a deficiency of plasma ADAMTS13 (a disintegrin-like metalloproteinase with thrombospondin type 1 motifs 13) activity, which is caused by genetic mutations in or acquired autoantibodies to this enzyme. ADAMTS13 specifically cleaves von Willebrand factor multimers (VWFMs) at the site of the Tyr1605-Met1606 bond of the VWF-A2 domain (4)
.
T a b l e 1 . L a b o r a t o r y F i n d i n g s o n Ad mi s s i o n
) prolonged prothombin time (PT), despite normal activated partial prothrombin time (A-PTT); 2) significantly reduced plasma level of antithrombin; 3) increased levels of plasma fibrinogen and two of its degradation products, FDP-P and D-dimer; 4) elevated levels of the DIC markers, thrombin-antithrombin complex (TAT) and plasmin-α2 plasmin inihibitor complex (PIC). Thus, by the diagnostic criteria for DIC from the International Society of Thrombosis and Haemostasis
, the patient had a DIC score of 4 (non-overt DIC), and by that from the Japanese Ministry of Health and Welfare (12) , the patient had a DIC score of 9 (overt DIC). However, ADAMTS13 assays in this patient gave evidence confirming a diagnosis of TTP, showing an extremely low level of plasma ADAMTS13 activity (less than 0.5% of the normal control) with a high titer of anti-ADAMTS13 inhibitor (6.0 Bethesda units/mL), using chromogenic act-ELISA (13) . The plasma level of ADAMTS13 antigen was 0.1% by ag-ELISA (14) .
After admission, the patient received high-dose methylprednisolone (one gram per day) therapy with concomitant
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Western blot studies of the patient's plasma, which had been stored at -80 , and the purified plasma-derived ADAMTS13, clearly identified that the immunoglobulin type of the inhibitor was IgG (6) (Fig. 1, inset) .
Discussion
In 1981, Wasserstein et al (15) 
